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Optimal drug proportions and mechanism deciphering of multicomponent drugs
are critical for developing novel therapies to cope with complex diseases, such
as stroke. In the present study, orthogonal experimental design was applied to
explore the optimal proportion of the four component herbs in Huang-Lian-Jie-Du-
Decoction (HLJDD) on the treatment of ischemic stroke. The treatment efficacies and
mechanisms were assessed using global and amino acids (AAs) targeted metabolomics,
as well as correlation network analysis. The global NMR metabolomics results
revealed that AAs metabolism was significantly perturbed in middle cerebral artery
occlusion rats. The levels of 23 endogenous AAs were then subjected to HPLC-
QTOF-MS/MS analysis. These results complemented with neurobehavioral evaluations,
cerebral infarct assessments, biochemical evaluations, histological inspections and
immunohistochemistry observations strongly demonstrated that HLJDD with optimal
proportion of 6 (Rhizoma coptidis): 4 (Radix scutellariae): 1 (Cortex phellodendr): 3
(Fructus Gardeniae) had the best efficacy on ischemic stroke, which could be ascribed to
its modulation on AA metabolism. This integrated metabolomics approach showed the
potential and applicable in deciphering the complex mechanisms of traditional Chinese
medicine formulae on the treatment of complicated diseases, which provided new
means to assess the treatment effects of herb combinations and to further development
of drugs or therapies based on these formulae.
Keywords: metabolomics, ischemic stroke, correlation network, orthogonal experimental design, amino acids,
middle cerebral artery occlusion, Huang-Lian-Jie-Du-Decoction
INTRODUCTION
Stroke is one of the leading causes of death and adult disability worldwide, and ischemic stroke
accounts for 87% of all forms of stroke patients (Strong et al., 2007; Lloyd-Jones et al., 2010).
Unfortunately, no effective and generally accepted treatment for ischemic stroke is available
now due to its complexity: multiple events occurred in ischemic stroke, such as excitotoxic
amino acids (AAs), inflammation, oxidative damage, ionic imbalances, apoptosis, angiogenesis
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and neuroethology injury. Therefore, it is a huge challenge to
rectify these abnormalities in clinic, especially with a single-target
drug or monotherapy. Increasing evidences in treating complex
illness such as ischemic stroke demonstrate that treatment
regimens containing multiple drugs with distinct but related
mechanisms can usually amplify the therapeutic efficacies of
each agent, leading to maximal therapeutic efficacy with minimal
adverse effects. Therefore, combination therapy has been a
rational and promising choice (Amarenco, 2006; Kernan et al.,
2010).
Actually, combination therapies have been advocated by
prescriptions in the form of formulae in traditional Chinese
medicine (TCM) for more than 2,500 years to prevent and
cure diseases based on clinical practice (Wang et al., 2008).
There is no doubt that, at least in some formulae, multiple
components could hit multiple targets simultaneously and exert
synergistic therapeutic efficacies. It is thus important to elucidate
the complex action mechanism of TCM formulae to improve
its clinical efficacy and safety, and for further drug or therapy
development (Wang et al., 2008). Understanding optimal drug
proportions and synergistic mechanisms of multicomponent
drugs are critical for developing novel strategies to cope with
complex diseases, such as stroke.
The double complexity of ischemic stroke and the components
of the formula created a far more difficult situation to assess
the efficacy of the formula, needless to say, to clarify the
combinatorial rules of herbal formula. Therefore, it’s urgent
to employ new methods to elucidate the complex action
mechanisms of TCM formulae, which is essential for further
development of drugs or therapies based on these formulae.
Metabolomics has been used as a versatile tool for the discovery of
disease-related biomarkers and in assessment of the therapeutic
effects of drug (Shah et al., 2012; Fan et al., 2016; Ma et al.,
2016). The holistic view of metabolomics is similar to the theory
and practice of TCM on the treatment of disease. Therefore, it
is reasonable to apply metabolomics technology to explore the
effects of drug combination and the underlying mechanisms of
TCM formula.
Huang-Lian-Jie-Du-Decoction (HLJDD, Oren-gedoku-to in
Japanese), consisting of Rhizoma coptidis (Rc), Radix scutellariae
(Rs), Cortex phellodendr (Cp), and Fructus Gardeniae (Fg), is
a famous TCM formula for heat clearance and detoxification,
which has been used to treat ischemic stroke in the clinical
practice of TCM in China and other Asian countries (Kawashima
et al., 1988; Kondo et al., 2000; Itoh, 2001). HLJDD acted
as a potential neuroprotective agent and offered protection
on ischemic injury (Hwang et al., 2002; Wang et al., 2014;
Zhang et al., 2015). However, the optimal proportions and
combinational mechanisms of HLJDD on the treatment of
ischemic stroke remain unidentified.
In the present study, a middle cerebral artery occlusion
(MCAO) rat model was used to mimic ischemic stroke, and
orthogonal experimental design was proposed to evaluate
the optimal proportions of the four component herbs in
HLJDD. Furthermore, proton nuclear magnetic resonance
(1H NMR)-based global metabolomics and high-performance
liquid chromatography time-of-flight mass spectrometry
(HPLC-QTOF-MS) targeted metabolomics, as well as metabolic
correlation networks were used to assess the combinational
mechanisms.
MATERIALS AND METHODS
Materials and the Preparation of
Formulae 1–9
Sodium 3-trimethylsilyl-propionic acid (TSP) was purchased
from Sigma (St. Louis, MO, USA). Deuterium oxide (D2O,
99.9%) was bought from Sea Sky Bio Technology Co. Ltd (Beijing,
China). Chloral hydrate was obtained from Sinopharm Chemical
Reagent Co. Ltd (Shanghai, China). Phenylisothiocyanate (PITC)
was purchased from Dalian Meilun Biotech Co., Ltd. (Dalian,
China). AAs standard solution was supplied from Sigma
(Taufkirchen, Germany, mix of 17 AAs in hydrogen chloride
solution, 2.5 mmol/L in 0.1 mol/L HCl, except for l-cystine
at 1.25 mmol/L). The standard consists of 17 AAs that are
l-Aspartic acid (Asp), l-Serine (Ser), l-Glutamate (Glu), l-
Glycine (Gly), l-Histidine (His), l-Arginine (Arg), l-Threonine
(Thr), l-Alanine (Ala), l-Proline (Pro), l-Cystine (Cys), l-
Tyrosine (Tyr), l-Valine (Val), l-Methionine (Met), l-Lysine
(Lys), l-Isoleucine (Ile), l-Leucine (Leu), and l-Phenylalanine
(Phe). Taurine (Tau), l-Glutamine (Gln), l-Ornithine (Orn), l-
Tryptophan (Trp), γ-AminoButyric Acid (GABA) and DL-2-
aminobutyric acid (2-ABA), and internal standard l-Norleucine
(IS) were obtained from Aladdin (Shanghai, China). Acetonitrile
(LC-MS grade), ammonium acetate and acetic acid (LC-MS
grade) were bought from ROE Scientific Inc. (Newark, NJ,
USA). The distilled water (Watsons Water, HK) used in the
experiment was filtered through 0.22 µm nylon membrane prior
to use.
Rhizoma Coptidis (Coptis chinensis Franch, Ranunculaceae),
Radix Scutellariae (Scutellaria baicalensis Georgi, Labiatae),
Cortex Phellodendri (Phellodendron chinensis Schneid, Rutaceae)
and Fructus Gardeniae (Gardenia jasminoides Ellis, Rubiaceae)
were provided by Jiangsu Medicine Company (Nanjing,
China, Drug GMP certificate: SUJ0623. Drug Manufacturing
Certificate: SUY20110051), and authenticated by Professor Mian
Zhang, Department of Medicinal Plants, China Pharmaceutical
University, Nanjing, China. Formulae 1–9 reaching a total
weight of 1.0 kg (the weight ratios were list in Supplementary
Table S1), were extracted with water (1:10, w/v) under reflux
for three times, 1 h each. The extract solutions were combined
and freeze-drying in vacuum to afford extracts of formulae
1–9 (the yields were list in Supplementary Table S1), which
were dissolved in 0.5% CMC-Na (carboxymethyl cellulose
sodium salt) to the final concentration of 5.0 g/ml (equivalent
to dry weight of raw materials) before intragastrical (i.g.)
administration.
Animal Handling Procedure and Drug
Administration
Male Sprague-Dawley rats weighing 250 ± 20 g were obtained
from the Experimental Animal Center of Yangzhou University
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(Yangzhou, China). All animals were housed in a well-ventilated
room (five rats in one cage) at a constant room temperature
(25 ± 2◦C) and controlled humidity (50 ± 10%), with a 12 h
dark-light cycle and free access to chow and water. The rats were
allowed to acclimatize for 7 days before the experiments. All
procedures for animal care and use were in accordance with the
National Institute of Health (NIH) guidelines for the Care and
Use of Laboratory Animals, and approved by the Institutional
Animal Care and Use Committee of China Pharmaceutical
University [license number: SYXK (Su) 2016-0011].
The MCAO model in rats was performed as previously
described (Wang et al., 2014). Briefly, animals were firstly
anesthetized with chloral hydrate (3.0%, 350 mg/kg, i.p.). The
right common carotid artery (CCA), the right external carotid
artery (ECA), and the right internal carotid artery (ICA)
were exposed and isolated from connective tissues. A poly-l-
lysine coated nylon monofilament (0.26 mm, 2636-A3, Beijing
Cinontech Co. Ltd., Beijing, China) with the tip heat rounded
diameter of 0.36 ± 0.02 mm) was inserted into the ICA through
the ECA until its tip was lodged in the anterior cerebral artery
(ACA), a distance of 18–20 mm from the carotid bifurcation
according to the weight of the animal, to obstruct the blood
flow into the middle cerebral artery (MCA), thus achieving
cerebral ischemia. After 2 h sustained ischemia, reperfusion was
performed by the withdrawal of the inserted filament. Sham-
operated rats received the same surgical procedures except
that the arteries were not occluded. All surgical operations
were done in a sterile environment. Rectal temperature of
the animal was monitored by a thermistor and maintained at
37.0 ± 0.5◦C with a thermostatically controlled heating pad
(ALCBIO, Shanghai, People’s Republic of China) during surgery
and ischemia.
In addition to the sham operation group (NC, n = 20)
and MCAO model group (M, n = 40), rats were randomly
assigned to nine treatment groups (F1–F9), treated by different
combination of HLJDD component herbs according to an
orthogonal experimental design (n = 40/group, Table 1). As
shown in Supplementary Figures S1–S6, 37 components in F1–F9
extracts were identified, mainly involving alkaloids, flavonoids,
terpenoids, phenols, iridoids and their glycosides (Supplementary
Tables S2–S6). Formulae 1–9 were dissolved in 0.5% CMC-
Na (carboxymethyl cellulose sodium salt) and intragastrically
TABLE 1 | The orthogonal experimental design L9(34) of HLJDD.
groups Rhizoma
Coptidis
Radix
Scutellariae
Cortex
Phellodendri
Fructus
Gardeniae
F1 3 2 2 3
F2 6 2 2 3
F3 3 4 4 6
F4 3 4 2 12
F5 3 2 8 6
F6 3 8 4 3
F7 12 4 8 3
F8 6 1 2 6
F9 6 4 1 3
(i.g.) administered to rats (5 g/kg, weight ratio between crude
drug and rat for each administration) once per day for 10
consecutive days, while the sham and MCAO groups were i.g.
administrated with an equivalent amount of 0.5% CMC-Na.
Rats in the MCAO group and nine treatment groups (F1–F9)
underwent MCAO surgery, while rats in the sham group only
received arteries separation without filament insertion. The rats
were fasted for 12 h before the operation of the MCAO model
but were allowed free access to water. The flow diagram of
the present experimental design was shown in Supplementary
Figure S7.
Orthogonal Experimental Design
To explore the optimal proportions of HLJDD, orthogonal
experimental design was used. For four parameters at three levels
each, the traditional full factorial design would require 34 or 81
experiments. However, current design (Taguchi L9 orthogonal
array) required only nine experiments (Yang and Tarng, 1998).
It uses an orthogonal table to organize the factors and levels
of each factor. The table is denoted as L9 (43), representing an
orthogonal design of nine experiments, involving four factors
at three levels (Supplementary Table S7). The details of the
orthogonal design of HLJDD were shown in Table 1, the four
component herbs of HLJDD were reformulated to eight HLJDD
variants F2–F9.
Neurological Defects and Infarct Volume
Measurements
At 24 h after reperfusion, each animal’s neurological function
was evaluated. The neurological scores were recorded by an
investigator who was blinded to the experimental groups
according to Longa’s five-point scale (Longa et al., 1989): 0, no
neurological deficit; 1, failure to extend right forelimb; 2, circling
to the contralateral side; 3, falling to the contralateral side at rest;
and 4, no spontaneous motor activity.
Cerebral infarct volumes were evaluated by 2,3,5-
triphenyltetrazolium chloride (TTC, Sigma) staining method
(Bederson et al., 1986). The brains were sectioned into six
2-mm-thick coronal slices, stained with 1% TTC, and incubated
at 37◦C for 30 min in the dark, and then fixed with 10% buffered
formalin overnight. Normal tissue was stained rose red, and
the infarct tissue was stained white. Slices stained with TTC
were photographed, and analyzed using image analysis software
(Image-Pro Plus 6.0). Tests were conducted by an observer
blinded to the treatment group. To correct infarct volume (V i)
for brain edema, the percentage of the infarction volumes (I%)
were obtained using following formula:
I% = (Vc− Vi)/Vc × 100%
Vc= volume of intact contralateral (left) hemisphere
Vi = volume of intact regions of the ipsilateral (right)
hemisphere (Zhang et al., 2006).
Biochemistry Evaluation
After 24 h of reperfusion, rats were sacrificed and brains were
removed. The homogenates extracted from the ischemic brain
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hemispheres were analyzed for biochemical parameters. The
levels of oxidative stress-related biological components,
including nitric oxide (NO), malondialdehyde (MDA),
superoxide dismutase (SOD), glutathione (GSH), glutathione
peroxidase (GSH-PX), and catalase (CAT) were measured using
commercially available kits (Nanjing Jiancheng Biotech Inc.,
China). People who analyzed the subsequent data did not know
this assignment.
Histopathology and
Immunohistochemical Examinations
The brain tissues were immersed in 10% neutral buffered
formaldehyde for 24 h, embedded in paraffin, and sliced
into 5 µm thickness. The sliced sections were stained with
haematoxylin and eosin (H&E), and examined by light
microscopy (×200 magnification, Olympus DX45). The
histopathology results were evaluated by Prof. Ning Su
(Southeast University, Nanjing, China) who was blinded to the
experiments.
For immunohistochemical examination, formalin-fixed,
paraffin embedded brain tissue sections were used and the
activities of glial fibrillary acidic protein (GFAP) and vascular
endothelial growth factor (VEGF) were evaluated by Goodbio
Technology Co., Ltd. (Nanjing, China). The staining was
photographed under light microscopy, and analyzed by a
researcher who was blinded to the experimental treatment
groups using image analysis software (Image-Pro Plus 6.0).
Global Metabolomics Study by NMR
Sample Preparation and 1H NMR Analysis
Cerebrum samples were homogenized and extracted according
to our previously published procedures (Wei et al., 2015).
Frozen ischemic hemisphere of brains (200–300 mg) were
homogenized in ice-cold solvent (50% acetonitrile/H2O, v/v,
5 ml/g tissue), vortexed and then centrifuged at 12,000 g for
10 min at 4◦C. The supernatant was collected and concentrated
under a stream of nitrogen and lyophilized. Dried cerebrum
extracts were reconstituted in 600 µL D2O phosphate buffer
(0.2 mol L−1 Na2HPO4 and 0.2 mol L−1 NaH2PO4, pH 7.4,
containing 0.05% TSP). TSP acted as a chemical shift reference
(δ 0.0), D2O provided a lock signal and phosphate buffer
was added to minimize NMR shift variation due to the pH
discrepancy. After vortexing and centrifugation at 12,000 g for
10 min at 4◦C to remove insoluble material, the transparent
supernatant solution was pipetted into 5 mm NMR tube for NMR
analysis.
1H NMR spectra of the samples were acquired at 298 K
on a Bruker Avance 500 MHz spectrometer (Bruker GmbH,
Karlsruhe, Germany). For each cerebrum tissue sample, a nuclear
overhauser effect spectroscopy (NOESYPR) pulse sequence
(relaxation delay-90◦-µs-90◦-tm-90◦-acquire-FID) was used to
attenuate the residual water signal. 1H NMR spectra were
measured with 128 scans into 32,768 (32 K) data points over a
spectral width of 10,000 Hz. Prior to Fourier transformation, an
exponential window function with a line broadening of 0.5 Hz
was used for the free induction decays (FIDs).
Spectral Pre-processing
The spectra for all samples were manually phased and baseline
corrected and referenced to TSP at 0.0 ppm, using Bruker
Topspin 3.0 software (Bruker GmbH, Karlsruhe, Germany). The
1H NMR spectra were automatically exported to ASCII files using
MestReNova (Version 8.0.1, Mestrelab Research SL), which were
then imported into “R”1 and aligned with an in-house developed
R-script to further reduce phase and baseline distortions. The
one-dimensional (1D) spectra were converted to an appropriate
format for statistical analysis by automatically segmenting each
spectrum into 0.015-ppm integrated spectral regions (buckets)
between 0.2 and 10 ppm. The region of the residual water and
affected signals (4.65–5.25 ppm) was removed. To account for
different dilutions of samples, all binned spectra were probability
quotient normalized and then mean-centered before further
multivariate analysis.
Data Analysis
The mean-centered and Pareto-scaled NMR data were analyzed
by principal component analysis (PCA) and orthogonal partial
least-squares discriminant analysis (OPLS-DA). PCA is an
exploratory unsupervised method to maximize the separation
by providing model-free approaches for determining the
latent or intrinsic information in the dataset. However, no
clustering was observed when variables were not selected. OPLS-
DA determined PLS components that are orthogonal to the
grouping and was used to concentrate group discrimination
into the first component with remaining unrelated variations
contained in subsequent components. The OPLS-DA model was
validated using a repeated two fold cross-validation (2CV) and
permutation test (2000 times) (Westerhuis et al., 2008) to reduce
the chance separation of the two categories and give confidence
to the predictive capacity of the models. The parameters R2 and
Q2 reflected the goodness of fitness and the predictive ability
of the models, respectively. The classification performance was
evaluated by analyzing the area under the receiver operating
characteristic curve (AUROC) and misclassification rate of
established models based on permutation test. The fold change
values of metabolites between groups were calculated by the
ratios of integral non-overlapping areas of each metabolite. The
Benjamini and Hochberg (1995) method was used to adjust
the p-values for controlling the false discovery rate in multiple
comparisons using scripts written in R language2. The fold change
values of metabolites and associated p-values adjusted by BH
methods in different group comparisons were visualized in fold
change plots (Supplementary Figure S8).
Targeted Metabolomics Study of Amino Acids (AAs)
by HPLC-QTOF-MS
In the targeted analysis, AAs were extracted from the brain tissues
and the developed method relies on derivatization of AAs to AA
butyl esters using PITC according to published methods with
modifications (Robert et al., 1984; Senden et al., 1992; Zheng et al.,
2015). Briefly, 100 µL of brain homogenate or AAs standard was
1http://cran.r-project.org/
2http://stat.ethz.ch/R-manual/R-devel/library/stats/html/p.adjust.html
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mixed with 10 µL of internal standard l-Norleucine solution in
a microcentrifuge tube. Then, 100 µL of 0.1 mol/L PITC-ACN
solution and 100 µL of 1.0 mol/L trimethylamine-ACN solution
were added and vortexed for 2 min. After incubating at room
temperature for 60 min, 400 µL of n-hexane was added, after
shaking for 1 min, standing for 10 min, the lower layer was
transferred into another microcentrifuge tube, and then subjected
to HPLC-QTOF-MS/MS analysis.
The HPLC analysis of the selected AAs was carried out using
an Agilent 1290 HPLC system (Agilent Technologies, Santa
Clara, CA, USA). The chromatography separation was performed
on an Agilent ZORBAX Eclipse Plus C18 column (2.1× 100 mm
I.D., 3.5 µm particle size) with a solvent flow rate of 1 ml/min
at 40◦C. The sample injection volume was set at 5 µl. The mobile
phase A was composed of 0.01 mol/L sodium acetate solution (pH
6.5) and acetonitrile in a ratio 93:7, and the mobile phase B was
water and acetonitrile in a ratio of 20:80. The solvent gradient
adopted was as follows: 0–12% B at 0–5 min, 12–15% B at 5–
5.1 min, 15–19% B at 5.1–6.1 min, 19–50% B at 6.1–6.2 min,
50–70% B at 6.2–7 min, 70–100% B at 7–9 min, 100% B at 9–
11.8 min, 100–0% B at 11.8–13 min, 0% B at 13–20 min. A 5-min
post-run time back to the initial mobile phase composition was
used after each analysis.
The mass spectrometric data was collected using a tandem
quadrupole time-of-flight mass spectrometer (Agilent
Technologies, Santa Clara, CA, USA) equipped with an
electrospray interface. Electrospray ionization (ESI) was used
as the ionization source, and the analysis was carried out
in negative mode. The conditions of the ESI source were
as follows: drying gas (N2) flow rate, 8.0 L/min; drying gas
temperature, 300◦C; nebulizer, 241 kPa (35 psig); capillary
voltage, 3500 V; fragmentor, 150 V; skimmer voltage, 65 V.
All the operations, acquisition and analysis of data were made
by Agilent Mass Hunter workstation software version B.04.00
(Agilent Technologies, MA, USA).
Metabolites Identified in 1H NMR Spectra of
Cerebrum Tissues
Representative 500 MHz 1H NMR spectra of cerebrum samples
from the sham, the MCAO, the F1-treated rats were shown in
Supplementary Figure S9 with the assignment of metabolites.
The signals were assigned by querying publicly accessible
metabolomics databases, such as MMCD3 and HMDB4, and
aided by Chenomx NMR suite 7.5 (Chenomx Inc., Edmonton,
AB, Canada). The detailed information of the metabolites was
listed in Supplementary Table S8.
Method Validation of LC-QTOF-MS/MS Analysis
The LC-QTOF-MS/MS analytical method was developed and
validated for simultaneous quantification of 23 AAs in rat
brain tissues. The method was validated by determining
the linearity, accuracy, precision, recovery, matrix effect, and
stability. Calibration was performed using a least-squares linear
regression of the peak area ratios of the AAs to the IS versus the
3http://mmcd.nmrfam.wisc.edu/
4http://www.hmdb.ca/
respective standard concentration. The low limit of quantification
(LLOQ) was obtained at the concentration that provided signal-
to-noise ratios larger than 10. The intra-day and inter-day
accuracy and precision were evaluated by determination at three
different concentrations of quality-control (QC) samples. The
intra-day precision was assessed by analysis of AAs in QC
samples on the same day. Inter-day precision was evaluated by
repeated analysis of AAs in QC samples over three consecutive
days. The recovery was assessed by comparing the peak area of
QC samples extracted from biological matrix with those pure
standards at the same concentration levels without extraction.
The matrix effect was evaluated by comparing the peak areas of
post-extraction blank plasma samples spiked with AAs to those of
the neat standards at the same concentration. The ratios ranged
from 85 to 115% were considered as no ionization suppression
or enhancement in this method. The stability of AAs in rat brain
tissues was assessed by analyzing the three levels of QC samples
under various conditions, including at room temperature for 4 h
(short-term stability), stored at −80◦C for 2 weeks (long term
stability), after three freeze/thaw cycles (−80 to 25◦C), and at
4◦C for 24 h in autosampler vials (post-preparative stability). The
samples were considered stable if assay values were within the
acceptable limits of accuracy (±15% RE) and precision (≤15%
RSD).
Correlation Network Analysis
Metabolic correlation networks were performed using the
R-package igraph software. In the networks, the nodes represent
the metabolites, and the lines between the nodes indicate
the biological relationships between the two corresponding
metabolites. The solid lines between the molecules indicate a
correlation between the molecules, the line colors of red and
blue display positive and negative relationships, respectively.
Metabolites of similar structures were connected by the dotted
lines, indicating a possible biochemical reaction between the
molecules.
This improved correlation networks could present both the
Pearson correlation coefficients among levels of metabolites and
their structure similarity. Common Pearson correlation networks
only visualized the correlations of metabolites in different status.
However, such correlations were not causation relationships.
The addition of structure similarity information enriched the
networks since that the substrates and products in nearly all
the biochemical reactions should be similar. In this context,
the high correlation between metabolites with great structure
resemblance might reflect a theoretically possible biochemical
reaction between them and thus causative effects.
Statistical Analysis
Assays were conducted at least three times unless otherwise
stated. All data, except for mortality were expressed as the
means ± standard deviation (SD). The data of model groups
was compared with that of sham groups and the data of the
other groups was compared with the model groups, respectively.
Statistical significance was performed using Student’s two-tailed
t-test for comparison between two groups and one-way analysis
of variance (ANOVA) followed by Tukey’s multiple comparison
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test when the data involved three or more groups. A p-value less
than 0.05 was considered to be statistically significant.
RESULTS
The Improvement of Neurological
Defects by Formulae 1–9
At 24 h after reperfusion, as shown in Figure 1A, compared
to the sham group, the mortality and the neurological score in
the MCAO group increased significantly, indicating that MCAO
was successfully induced. While in F1, F5, and F9 treated rats,
the mortalities and the neurological scores were significantly
reduced compared to MCAO rats. According to the quantitative
analysis of the infarct volumes and TTC staining of cerebral
slices (Figures 1A,B), ischemia/reperfusion (I/R) significantly
increased the cerebral infarct volume (37.85± 2.17%), which was
significantly attenuated by F1, F5, and F9 treatments.
Biochemical Analysis
In our experiment, the levels of oxidative stress-related
biologicals were measured (Figure 1C). Compared with the sham
group, NO and MDA were significantly increased in the I/R
group and were decreased markedly in the F1, F5, and F9 groups.
The activities of the antioxidases SOD, CAT, and GSH-Px were
apparently inhibited in the MCAO group compared with the
sham group, which were greatly augmented by treatments with
F1, F5, and F9. I/R produced a notable reduction in the quantity
of GSH in the MCAO group, which was reversed by F1, F5, and
F9 treatments.
Histopathological Assessment and
Immunohistochemical Analysis
Apparent pathological changes occurred in cerebrum tissues
of MCAO rats: destructed neuron structure, neuronal loss
and numerous vacuolated spaces. F1, F5, and F9 treatments
remarkably ameliorated pathological changes in the brain
tissues of MCAO rats, while pathological abnormalities were
occasionally observed for the F4 and F8 groups (Figure 2A).
The effects of F1–F9 on the expression of GFAP (the
major protein constituent of glial intermediate filaments in
differentiated fibrous and protoplasmic astrocytes of the central
nervous system) (Xia et al., 2004) and VEGF (a key regulator of
physiological and pathological angiogenesis) (Storkebaum et al.,
FIGURE 1 | Mortality, neurological deficits, and infarct volume. (A) Mortality, neurobehavioral scores and infarct volume examinations. (B) TTC staining of
brains (n = 6). (C) Boxplots for brain tissue levels of NO, MDA, SOD, GSH, GSH-Px, and CAT in each group. At the bottom of each box, the lines drew in the box
and at the top of the box represent the 1st, 2nd, and 3rd quartiles, respectively. The whiskers extended to ±1.5 times the interquartile range (from the 1st to 3rd
quartile). All data are expressed as mean ±SD, n = 6. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 MCAO group vs. sham group;#p < 0.05, ##p < 0.01, and
###p < 0.001 Treatment groups vs. MCAO group.
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FIGURE 2 | H&E and immunohistochemical staining. (A) Histopathological examination of brain tissues by H&E staining (×200, n = 4). (B) The expression of
GFAP and VEGF in brain tissues of rats as determined by immunohistochemical staining (×400, n = 4). (C) The protein levels of GFAP and VEGF in brain tissues of
rats determined by immunohistochemical staining. Results of quantitative analysis values are expressed as mean ±SD (n = 4). ∗∗∗p < 0.001 MCAO group vs. sham
group; #p < 0.05, ##p < 0.01, and ###p < 0.001 Treatment groups vs. MCAO group.
2004) after I/R was investigated using immunohistochemical
analysis. Compared with sham groups, the positive cells
expression of GFAP and VEGF are significantly increased in
MCAO rats. F1, F5, and F9 treatments notably reduced the
levels of GFAP and VEGF activity in the ischemic stroke
(Figures 2B,C).
Method Validation
To determine the concentration of 23 endogenous AAs in
rat brains quantitatively and simultaneously, a LC-QTOF-
MS/MS analytical method was developed and validated.
Supplementary Figure S10 displays the UV chromatogram,
total ion chromatogram (TIC) and extract ion chromatogram
(EIC) of 23 AAs standard solution. The peak of each AA was
identified by the comparison of the molecular weights and
retention times. The concentration range of all standard curves
varied as shown in Supplementary Table S9. The correlation
coefficient (r2) for all analyses was above 0.993, indicating a good
linearity. The LLOQs of all AAs analyzed were about 1 µmol/L.
The intra- and inter-day accuracy and precision of the method
were summarized in Supplementary Table S10. The accuracy
and precision of the present method strictly conformed to the
criteria for the analysis of biological samples where the RSD
determined at each level did not exceed 15%. The recoveries and
matrix effects of the AAs during the sample preparation process
were ranged from 86 to 108% (Supplementary Table S11), which
showed that this method gave acceptable recovery and was with
no obviously matrix effect. The results from all stability tests
are presented in Supplementary Table S12, which demonstrated
a good stability of AAs over all steps of the determination at
4◦C. The samples were stable after three freeze-thaw cycles and
freezing for 2 weeks at −80◦C. The RSD of reproducibility did
not exceed 15%; the method, therefore, was proved to be reliable
and applicable to routine analysis.
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Identification of Significant Metabolites
through Global Metabolomics
Multivariate Analysis of 1H NMR Data of All Groups
1H NMR data of cerebrum extracts from the sham, MCAO and
formulae 1–9 treated groups were analyzed by OPLS-DA model
to investigate the effects of formulae 1–9 on MCAO rats. In the
score plots, the showcased clusters corresponded to metabolic
patterns in different groups with each point representing one
sample. As shown in Figure 3, the global metabolic patterns of
F1, F5, and F9 treated groups were clearly distinguishable with
the MCAO group, and similar to the sham group. Though the
groups treated with F2, F4, F6, F7, and F8 were distinguishable
with the MCAO model group, they were also well separated from
the control group, which reflected the bias of these therapies that
radically affected the metabolic status of the control group. The
fact that group NC and groups F1, F5, and F9 had a similar
metabolic phenotype suggested that F1, F5, and F9 pretreatment
prevented the changes of brain metabolites in MCAO rats with
I/R injury and slightly affected the metabolic status of the control
group. Above all, the F9 treatment group and the sham group
were severely overlapped with each other, showcasing the great
ability of F9 to protect against metabolic disturbance following
the MCAO injury.
Metabolic Alterations in MCAO and Formulae 1–9
Treated Rats
To further investigate the metabolic perturbations induced
by MCAO and find out metabolites that were directly
associated with the treatment effects of formulae 1–9, 1H
NMR data belonging to the MCAO group were compared
with the sham group and F1–F9 groups by OPLS-DA analysis,
individually.
The score plots for cerebrums presented a clear clustering
of the sham and MCAO groups with a well goodness of fit
(R2Y = 0.91, Q2Y = 0.82, Figure 4 and Supplementary Figure
S11A), indicating excellent models. Model validity was verified
FIGURE 3 | Score plots for OPLS-DA analysis based on 1H NMR spectra. Score plots for OPLS-DA analysis based on 1H NMR spectra of cerebrum extracts
obtained from the sham, the MCAO and all treated rats (A–I for F1–F9, respectively).
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FIGURE 4 | Loading plots for OPLS-DA analysis based on 1H NMR spectra. OPLS-DA analysis based on 1H NMR spectra of cerebrum extracts obtained
from the sham, the MCAO and alltreated rats. Score plots (A1–J1) and the loading plots of OPLS-DA (A2–J2) were analyzed after the removal of H2O signals.
Metabolite variation was visualized by the color-coded loading plots.
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using permutation tests where the predictive capability of a model
using real class assignments was compared with a number of
models calculated after random permutation of the class labels.
The diagnostic model statistics AUROC (Supplementary Figures
S12A1–J1) and misclassification rate (Supplementary Figures S12
A2–J2) were calculated based on a 2,000 times permutation test.
An empirical p-value was calculated by determining the number
of times the permutated data yielded a better result than the
one using the original labels. The observed statistic p-values
via permutation testing were all less than 0.05, thus suggesting
statistically significant separation of classes and the validity
of the OPLS-DA model. OPLS-DA loading plots (Figure 4)
and S-plots (Supplementary Figure S11B) were generated to
identify the main metabolites responsible for the differentiation
in the score plots. The color-coded loading plots were color-
encoded according to the absolute correlation coefficient of each
variable to grouping, a hot-colored signal (red) indicated more
significant contribution to class separation than a cold-colored
one (blue), and presented in a covariance-based pseudo-spectrum
(Hamabe et al., 2005). S-plots were another way to identify
significantly altered metabolites, which should be located in the
upper right or lower left quadrant and farther away from the
origin.
The loading plots and S-plots showed obvious increases
of leucine, isoleucine, lactate, alanine, lysine, glutamate,
GABA, glycine, glycerol, serine, histamine, methionine and
phenylalanine, and significant decreases of NAA, aspartate, GSH,
ascorbic acid, taurine, AMP, arginine, pyruvate and citrate in
MCAO group as compared with the sham group.
Univariate Analysis of 1H NMR Data of All Groups
These important differential metabolites identified by OPLS-DA
loading plots and S-plots were further tested for their between-
group difference using univariate analysis and visualized in the
heatmap (Figure 5). There was no statistical difference between
the F9 treatment group and sham group, which were clustered
together, showcasing the great ability of F9 to protect against
metabolic disturbance following the MCAO injury.
Metabolite Correlation Network Analysis in Global
Metabolomics
Instead of only investigating the individual metabolite variation,
metabolic correlation networks were performed to decipher the
biological correlation between the candidate biomarkers and
illustrate the links in the potential biomarker metabolic pathway.
The differential metabolic correlation networks were constructed
based on the differential metabolites in sham and all treated
groups (F1–9) compared to the MCAO group, and applied to
further compare the outcome of sham and all treated groups
(Supplementary Figure S13). Correlations between metabolites
that exist in the networks are potentially more interesting and
can offer insights into metabolic pathways that are altered
between the sham and MCAO groups, the F1–F9 treatments
and MCAO groups, respectively. For the differential network
between NC and MCAO (Figure 6A), alteration of metabolic
regulation is highlighted particularly well by threonine, which
was located in the center of the network and highly correlated
with many metabolites, including AMP, glycerol, histidine,
inosine, TMA, serine, hypoxanthine, xanthine, fumarate, and
cysteine. This suggested a considerable change in metabolic
regulation occurred between the sham and MCAO groups. Some
obvious differences were observed between the sham and F1–
8 differential networks, however, the sham and F9 differential
networks show several similarities. For the differential network
between F9 and MCAO (Figure 6B), threonine, fumarate,
tryptophan, lysine, serine, tyrosine were located in the center
of the networks and highly correlated with many metabolites,
including histidine, AMP, phenylalanine, inosine, creatine, and
PCr. All the results suggested that AA metabolism accounted
for a large proportion of the pathway alterations induced by I/R
and might be responsible for the treatment effects of F9 in the
ischemic stroke.
Identification of Significant Metabolites
through Targeted Metabolomics
Targeted Metabolomics Analyses of AAs in Cerebrum
Tissues
The global metabolomics study showed that a few AAs play
an important role in the metabolic correlation network. For
the metabolic changes of AAs in the eleven groups of rats
to be more comprehensively and accurately monitored, 23
AAs (Asp, Glu, Cys, Ser, Gln, Gly, His, Tau, GABA, Thr,
Arg, Ala, Pro, 2-ABA, Tyr, Val, Met, Ile, Leu, Phe, Trp, Orn,
Lys) were accurately quantified through a subsequent targeted
metabolomics analysis. A supervised OPLS-DA model with the
23 AAs was successfully established to discriminate the sham
and model groups. The OPLS-DA score plots (Supplementary
Figure S14) of AAs showed a clear differentiation between these
two groups at 24 h after I/R, suggesting that marked changes
in the levels of AAs occurred during the ischemic injury. In
addition to NC group, only F9 group was completely separated
from the M group, others were partially overlapped with the
M group, demonstrating the severe AAs disturbance induced
by MCAO could be ameliorated after F9 treatment. According
to the three-dimensional diagrams of OPLS-DA loading plots
(Figure 7), the concentrations of 14 AAs (Glu, Asp, Ile, Leu,
GABA, Gly, Thr, Ala, Lys, Phe, Met, Trp, Ser, and Orn) were
increased significantly, but the 2-ABA, Arg, Tau, and Pro levels
dropped dramatically in the brain tissues after MCAO, compared
with those of sham rats. Formula 9 significantly attenuated the
increase in Glu, GABA, Gly, Asp, Phe and Thr and the decrease
in 2-ABA, Arg and Pro induced by ischemic injury at 24 h
after reperfusion. Above all, F9 had significant effects on the
AA levels in rat brain tissues following MCAO. Glu, Asp, Thr,
Phe, GABA, Gly, Ser, and Arg were identified as the biomarkers
that may play a role in the anti-cerebral ischemia effects of
F9.
Correlation Network Analysis of Amino Acids in
Targeted Metabolomics
The metabolic AAs profiling data was further analyzed
by correlation network analysis to decipher the biological
correlation between the candidate AA biomarkers. As shown
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FIGURE 5 | Heatmap visualization of the metabolites in cerebral extracts. Heatmap visualization of the z-scored levels of metabolites in cerebral extracts with
stars denoting the significance. Rows represent metabolites and columns represent groups. Color key indicates metabolite quantities, white: no significant change,
deep red: highest, deep blue: lowest. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001, all groups were compared with the sham group (NC).
in Supplementary Figure S15, the differential networks of AAs
were constructed based on the differential AAs in brain tissues
of sham and F1–9 groups, compared to MCAO rats. Some
clear differences were observed between the sham and F1–F8
differential networks, while the F9 differential network was
similar to sham differential network.
For the NC differential network of AAs (Figure 6C), Thr,
Val, and Ala were in the center of the network, and highly
correlated with many AAs. A strong positive correlation was
observed between Val and His, Val and Cys, Thr with Gln,
Thr with Gly, Thr with Ile, Ala with Ser, respectively. Strong
negative correlations among Val and Glu, Ala and 2-ABA
were also observed. These correlations were absent for F1–
8 differential networks but were still found in F9 differential
network (Figure 6D). An example of AAs correlated in both NC
and F9 differential networks was that Thr, Val, and Ala were in the
center of the network, and have strong correlations with other
AAs. Our results demonstrated that the perturbed correlation
network of AAs in the MCAO rats could be partially rectified
by F9.
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FIGURE 6 | Correlation networks of differential metabolites and amino acids (AAs) in cerebral extracts. Differential network between NC and MCAO
groups (A) and differential network between F9 and MCAO groups (B); Differential network of AAs between NC and MCAO groups (C) and differential AAs network
between F9 and MCAO groups (D). Only correlations with absolute values of correlation coefficients greater than 0.3 and p-values < 0.05 were screened out. The
nodes represent the metabolites, and the lines between the nodes indicate the biological relationships between the two corresponding metabolites. The red (blue)
metabolites represent the upregulated metabolites (the downregulated metabolites) in MCAO rats compared with the sham rats or in drug-treated rats compared
with the MCAO rats. The solid lines between the molecules indicate a correlation between the molecules, the line colors of red and blue display positive and negative
relationships, respectively. Metabolites of similar structures were connected by the dotted lines, indicating a possible biochemical reaction between the molecules.
DISCUSSION
In this study, the global and AAs-based targeted metabolomics
approach integrated with metabolic correlation networks has
been established to evaluate the treatment effects of nine
groups (F1–F9) of different combination of HLJDD component
herbs according to an orthogonal experimental design on
ischemic stroke and to explore the underlying mechanisms.
Our results strongly demonstrated that HLJDD with optimal
proportion 6(Rc): 4(Rs): 1(Cp): 3(Fg), namely F9, exhibited
the strongest therapeutic effects in the MCAO models among
all treated groups (F1–F9), which could be ascribed to its
modulation on AA metabolism. F9 had good pharmacological
effects on ischemic stroke was also demonstrated by various
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FIGURE 7 | The three-dimensional diagrams of OPLS-DA loading plots for AAs. Score plots (A,B) and the three-dimensional diagrams of loading plots (C–F)
for OPLS-DA analysis based on AAs targeted metabolomics analysis of cerebrum extracts obtained from the sham, the MCAO and all treated rats. (C,D) NC group
VS. MCAO group; (E,F) F9-treated group VS. MCAO group.
indexes such as neurobehavioral evaluations, cerebral infarct
assessments, biochemical evaluations, histological inspections
and immunohistochemistry observations. Compared to HLJDD
(F1) and other HLJDD variants (F2–F8), F9 have an increased
proportion of Rhizoma coptidis and Radix scutellariae, which
might be responsible for its superior efficacy over other
combinations. The results of the present study indicate that
increase of either Rhizoma coptidis (F2, F7, and F8) or Radix
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scutellariae alone (F6) has no apparent augmentation of the
therapeutic effects, but increases of both Rhizoma coptidis and
Radix scutellariae together (F9) could obviously enhance the
efficacy in treating ischemic stroke.
The global metabolomics results combined with metabolic
correlation network analysis revealed that AAs metabolism
was significantly perturbed in MCAO rats. For the differential
network between NC and MCAO, threonine was located
in the center of the network and highly correlated with
many metabolites, including AMP, glycerol, histidine, inosine,
TMA, serine, hypoxanthine, xanthine, fumarate and cysteine,
thus it might have biochemical significance. Among them,
fumarate, the key intermediate of the TCA cycle, was highly
correlated with five metabolites (threonine, serine, tyrosine,
and tryptophan), however, these correlations were absent for
MCAO rats, indicating a shift of energy production from aerobic
respiration toward anaerobic glycolysis in MCAO rats. AMP,
inosine, hypoxanthine, and xanthine are associated with energy
metabolism. ATP produced by energy-inefficient glycolysis could
not suffice energy need of brain, which thus necessitated
the catabolism of ATP to adenosine, and further to inosine,
hypoxanthine and xanthine to provide more energy (Barsotti and
Ipata, 2004).
Notably, strong negative correlations were observed among
Cr, PCr, 3-Me, Ino, and Hyp in differential network between
F9 and MCAO, which suggested that F9 greatly improved the
damaged energy metabolism in MCAO rats. The Cr-PCr system,
through the creatine kinase (CK) reaction, played crucial roles
in maintaining a constant ATP level (Chen et al., 2012). With
the improved energy supply in F9 group, the other energy
production means were no longer necessary as exemplified by
the elevated Cr level, and reduced ketone body (3-HB) level
in brains of F9 rats, as compared with those in the MCAO
rats.
Glutathione (a tripeptide consisting of glutamate, cysteine,
and glycine) and ascorbate were also screened as key nodes in the
sham compared MCAO network. They are low-molecular weight
ROS scavengers and critical to attenuate the injury induced by
I/R (Chamorro et al., 2002; Ozkul et al., 2007; Dasuri et al., 2013).
It is well known that ischemic stroke is a disease in which free
radicals are involved (Cherubini et al., 2005; Crack and Taylor,
2005). The lower level of ascorbate in MCAO rats implied an
increased generation of free radicals. Compared with the MCAO
rats, GSH and ascorbate were significantly increased in brains
of F9 rats, which was helpful for the body to counteract ROS
and ameliorate the status of oxidative stress induced by I/R
injury. Consistent with these results, F9 significantly lowered
the increased levels of oxidative stress markers (NO and MDA),
and enhanced the activities of antioxidases (SOD, CAT, and
GPx) and the level of GSH, as compared with the MCAO
group.
Excitatory AAs (glutamate and aspartate) and inhibitory
AAs (GABA, glycine) were proved to be key nodes in the
differential network between sham and MCAO groups. The
MCAO rats showed significant increase in both excitatory
AAs (glutamate) and inhibitory AAs (GABA, glycine) levels in
cerebrum, indicating cerebrum damage. Since the discovery of
ischemia-evoked releases of glutamate in the rat hippocampus,
evidence has accumulated during the past two decades showing
that the excessive release of excitatory AAs such as glutamate is
the pathological mechanism behind ischemic cerebrum damage
(Saransaari and Oja, 1998; Nishizawa, 2001). Inhibitory AAs,
such as GABA and glycine, have also been reported to be released
during cerebral ischemia as a protection to alleviate the severity
of ischemic injury and to counteract the toxicity of excitatory AAs
(Bie et al., 2007). It is well established that during brain ischemia,
glutamate plays an important role in mediating neuronal damage,
and higher glutamate concentrations in the blood and CSF are
associated with an increased neurological deterioration after
stroke in humans and rats (Castillo et al., 1997). In animal
models of stroke, glutamate scavenging has provided promise as
a potentially useful therapeutic intervention. After F9 treatment,
glutamate, aspartate, GABA and glycine were restored to the
normal levels, indicating that F9 could not only restore the
increased levels of excitatory neurotransmitters in MCAO, but
also is good at restoring the level of inhibitory neurotransmitters
in MCAO.
Interestingly, we observed significantly decreased levels of
another key node N-acetylaspartic acid (NAA) in cerebrum of
MCAO rats. NAA, the second most concentrated molecule in
the cerebrum after glutamate, is used as an indicator of neuronal
death in early stage. Previous studies have furnished strong
evidence to support the view that NAA is an in vivo maker of
neuronal density and its reduction is related to neuronal damage
and loss in many cerebral disorders (Demougeot et al., 2001;
Moffett et al., 2007).
In summary, the integrated analyses of the global
metabolomics and correlation networks provided evidence
of energy imbalance, oxidative stress and a disordered AA
metabolism in ischemia reperfusion injury. Among all the
parameters, AA metabolism accounted for a large proportion of
the pathway alterations induced by I/R and might be responsible
for the treatment effects of F9 in the ischemic stroke.
A total of 23 endogenous AAs were then simultaneously
determined in rat brain tissues based on HPLC-QTOF-MS/MS
method. OPLS-DA analysis of the AAs profiles suggested better
therapeutic effects of F9 on the treatment of MCAO rats. We
observed significant correlations of AAs in sham differential
networks that appear to be separated into three clusters, such
as threonine cluster, alanine cluster and valine cluster. More
importantly, threonine and valine were the hubs of both the
global metabolic correlation network and the AAs metabolic
correlation network, which complemented each other. These
data provided further support for the major impact of a
disordered AA metabolism on the development of ischemic
stroke.
It is undoubtedly a new trial to explore the optimal
proportional of Rc, Rg, Cp, and Gf in treating cerebral ischemia
by examining the AAs metabolic profiling. The results from AAs-
based targeted metabolomics complemented with NMR global
metabolomics suggested that altered AA levels may serve as
diagnostic biomarkers for stroke. AA metabolic profiling sufficed
to diagnostically denote the therapeutic effects of combinational
drugs on ischemic stroke.
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So far, we proposed optimal proportion of the four component
herbs in HLJDD as a combination drug for the first time
with the assistance of orthogonal design and global and AAs-
based targeted metabolomics methods. All of these results
indicated that in the treatment of acute ischemic stroke, we
should pay more attention to the AA metabolism. These
findings suggested an association between disorders of AA
metabolism and ischemic stroke, and that the hypothesis
was strongly supported by earlier reports on excitotoxic AAs
and the risk of ischemic stroke (Castillo et al., 1997). This
integrated metabolomics approach provides a new method
to investigate and understand the molecular mechanism of
TCM, and AA metabolism could be promising targets to
treat ischemic stroke and predict the prognosis of stroke
disease.
CONCLUSION
In this study, global and AAs targeted metabolomics approach
combined with correlation network analysis was firstly used to
explore the optimal proportional of the four components in
HLJDD for the treatment of ischemic stroke, which disclosed
AAs metabolism as the major targets underlying the treatment of
stroke by HLJDD variants. These findings demonstrated a strong
association between disorders of AA metabolism and ischemic
stroke. Our study showed the potential and applicable of this
integrated metabolomics approach in deciphering the complex
mechanisms of TCM formula on the treatment of complicated
diseases, which provided new means to assess the treatment
effects of herb combinations.
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